Early research (Phase 1)Looking for participantsNCT05773040
What this trial is testing
JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
Who this might be right for
LymphomasB-cell Lymphomas
M.D. Anderson Cancer Center 33